Burkholderia oklahomensis agglutinin is a canonical two-domain OAA-family lectin: structures, carbohydrate binding and anti-HIV activity

被引:26
作者
Whitley, Matthew J. [1 ]
Furey, William [2 ,3 ]
Kollipara, Sireesha [4 ]
Gronenborn, Angela M. [1 ]
机构
[1] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15261 USA
[2] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA
[3] Vet Affairs Med Ctr, Biocrystallog Lab, Pittsburgh, PA USA
[4] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA
基金
美国国家卫生研究院;
关键词
anti-HIV activity; high-mannose glycans; lectins; NMR; X-ray crystallography; CYANOVIRIN-N; ENVELOPE GLYCOPROTEIN; HIGHLY POTENT; CD4; RECEPTOR; VIRUS; INHIBITOR; PROTEIN; CYANOBACTERIUM; TRANSMISSION; SPECIFICITY;
D O I
10.1111/febs.12229
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Burkholderiaoklahomensis EO147 agglutinin (BOA) is a 29kDa member of the Oscillatoriaagardhii agglutinin (OAA) family of lectins. Members of the OAA family recognize high-mannose glycans, and, by binding to the HIV envelope glycoprotein 120 (gp120), block the virus from binding to and entering the host cell, thereby inhibiting infection. OAA-family lectins comprise either one or two homologous domains, with a single domain possessing two glycan binding sites. We solved the structure of BOA in the ligand-free form as well as in complex with four molecules of 3,6-mannopentaose, the core unit of the N-linked high-mannose structures found on gp120 invivo. This is the first structure of a double-domain OAA-family lectin in which all four binding sites are occupied by ligand. The structural details of the BOAglycan interactions presented here, together with determination of affinity constants and HIV inactivation data, shed further light onto the structurefunction relationship in this important class of anti-HIV proteins. Database The atomic coordinates and structure factors for ligand-bound and ligand-free BOA have been deposited into the Protein Data Bank under accession numbers 4GK9 and 4GU8, respectively.
引用
收藏
页码:2056 / 2067
页数:12
相关论文
共 39 条
[1]   PHENIX: a comprehensive Python']Python-based system for macromolecular structure solution [J].
Adams, Paul D. ;
Afonine, Pavel V. ;
Bunkoczi, Gabor ;
Chen, Vincent B. ;
Davis, Ian W. ;
Echols, Nathaniel ;
Headd, Jeffrey J. ;
Hung, Li-Wei ;
Kapral, Gary J. ;
Grosse-Kunstleve, Ralf W. ;
McCoy, Airlie J. ;
Moriarty, Nigel W. ;
Oeffner, Robert ;
Read, Randy J. ;
Richardson, David C. ;
Richardson, Jane S. ;
Terwilliger, Thomas C. ;
Zwart, Peter H. .
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2010, 66 :213-221
[2]  
Alkhatib G, 2007, EUR J MED RES, V12, P375
[3]   The highly specific carbohydrate-binding protein cyanovirin-N: Structure, anti-HIV/Ebola activity and possibilities for therapy [J].
Barrientos, LG ;
Gronenborn, AM .
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2005, 5 (01) :21-31
[4]   Cyanovirin-N potently inhibits human immunodeficiency virus type 1 infection in cellular and cervical explant models [J].
Buffa, Viviana ;
Stieh, Daniel ;
Mamhood, Naheed ;
Hu, Qinxue ;
Fletcher, Patricia ;
Shattock, Robin J. .
JOURNAL OF GENERAL VIROLOGY, 2009, 90 :234-243
[5]   Oligomeric structure of the human immunodeficiency virus type I envelope protein on the virion surface [J].
Center, RJ ;
Leapman, RD ;
Lebowitz, J ;
Arthur, LO ;
Earl, PL ;
Moss, B .
JOURNAL OF VIROLOGY, 2002, 76 (15) :7863-7867
[6]   Roles of conformational and positional adaptability in structure-based design of TMC125-R165335 (etravirine) and related non-nucleoside reverse transcriptase inhibitors that are highly potent and effective against wild-type and drug-resistant HIV-1 variants [J].
Das, K ;
Clark, AD ;
Lewi, PJ ;
Heeres, J ;
de Jonge, MR ;
Koymans, LMH ;
Vinkers, HM ;
Daeyaert, F ;
Ludovici, DW ;
Kukla, MJ ;
De Corte, B ;
Kavash, RW ;
Ho, CY ;
Ye, H ;
Lichtenstein, MA ;
Andries, K ;
Pauwels, R ;
de Béthune, MP ;
Boyer, PL ;
Clark, P ;
Hughes, SH ;
Janssen, PAJ ;
Arnold, E .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (10) :2550-2560
[7]   NMRPIPE - A MULTIDIMENSIONAL SPECTRAL PROCESSING SYSTEM BASED ON UNIX PIPES [J].
DELAGLIO, F ;
GRZESIEK, S ;
VUISTER, GW ;
ZHU, G ;
PFEIFER, J ;
BAX, A .
JOURNAL OF BIOMOLECULAR NMR, 1995, 6 (03) :277-293
[8]   Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity [J].
Dorr, P ;
Westby, M ;
Dobbs, S ;
Griffin, P ;
Irvine, B ;
Macartney, M ;
Mori, J ;
Rickett, G ;
Smith-Burchnell, C ;
Napier, C ;
Webster, R ;
Armour, D ;
Price, D ;
Stammen, B ;
Wood, A ;
Perros, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (11) :4721-4732
[9]   Coot:: model-building tools for molecular graphics [J].
Emsley, P ;
Cowtan, K .
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2004, 60 :2126-2132
[10]   Darunavir, a conceptually new HIV-1 protease inhibitor for the treatment of drug-resistant HIV [J].
Ghosh, Arun K. ;
Dawson, Zachary L. ;
Mitsuya, Hiroaki .
BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (24) :7576-7580